Aptevo Therapeutics Inc.
APVONasdaqCIK 1671584HealthcareFiscal year ends Dec 31
Reports and events: 254 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2608:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-431079 |
| 2026-10-2316:05 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-26-430419 |
| 2026-10-1408:52 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-421076 |
| 2026-09-2408:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-400213 |
| 2026-09-2316:43 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-399545 |
| 2026-09-0308:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-381098 |
| 2026-08-3117:29 ET | DEF 14A | Proxy statementPeriod 2026-09-22 | 0001193125-26-376763 |
| 2026-08-2116:10 ET | S-1 | Registration statement | 0001193125-26-361103 |
| 2026-08-2116:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-361079 |
| 2026-08-1408:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-350559 |
| 2026-08-1408:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-350537 |
| 2026-08-1316:37 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-349380 |
| 2026-07-3116:15 ET | DEF 14A | Proxy statementPeriod 2026-07-31 | 0001193125-26-328604 |
| 2026-07-2716:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-318056 |
| 2026-06-3016:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-290473 |
| 2026-05-2716:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-241867 |
| 2026-05-1316:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-221661 |
| 2026-05-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-221593 |
| 2026-05-0616:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-208958 |
| 2026-03-2616:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-126278 |
| 2026-03-2616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-126190 |
| 2026-03-1117:59 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-100539 |
| 2026-02-1919:24 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-057707 |
| 2026-02-0308:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-034473 |
| 2026-01-2816:05 ET | S-1 | Registration statement | 0001193125-26-027200 |
| 2026-01-2616:05 ET | DEF 14A | Proxy statementPeriod 2026-01-23 | 0001193125-26-022560 |
| 2026-01-0908:17 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-008318 |
| 2025-12-2917:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-335497 |
| 2025-12-0917:23 ET | 8-K | 9.01 Financial statements and exhibits | 0001193125-25-312972 |
| 2025-11-0616:18 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269598 |
| 2025-11-0616:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269470 |
| 2025-10-3016:30 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-25-258665 |
| 2025-10-0116:30 ET | S-1 | Registration statement | 0001193125-25-226825 |
| 2025-09-1617:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-205107 |
| 2025-09-0416:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001671584-25-000005 |
| 2025-08-1108:12 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106247 |
| 2025-08-1108:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106246 |
| 2025-07-2516:15 ET | S-1 | Registration statement | 0000950170-25-098788 |
| 2025-07-2417:28 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-098429 |
| 2025-07-0312:11 ET | DEF 14A | Proxy statementPeriod 2025-07-24 | 0000950170-25-093924 |
| 2025-07-0117:05 ET | 8-K | 8.01 Other events | 0000950170-25-092318 |
| 2025-06-3016:15 ET | 8-K | 8.01 Other events | 0000950170-25-091581 |
| 2025-06-2316:05 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-25-088970 |
| 2025-06-2017:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-088592 |
| 2025-06-2016:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-088494 |
| 2025-06-1716:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-087368 |
| 2025-06-1608:15 ET | S-1 | Registration statement | 0000950170-25-086548 |
| 2025-05-2317:10 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000950170-25-077089 |
| 2025-05-2217:29 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-076482 |
| 2025-05-1516:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-072622 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:45 ET. Listed shows no prices and gives no investment advice.